Trials / Completed
CompletedNCT05347667
Menstrual Cycle Phase and Oral Contraceptive Pill (OCP) Use on Muscle Protein Synthesis
Influence of Menstrual Cycle Phase and Oral Contraceptive Pill (OCP) Use on the Muscle Protein Synthetic Response to Exercise in Young, Healthy Women
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- McMaster University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
Skeletal muscle size and function is regulated by various factors, including hormones. While we understand the role of male sex hormones (testosterone), we aren't sure how female sex hormones (estrogen and progesterone) influence muscle mass and strength. Female physiology is unique in that hormones fluctuate throughout the menstrual cycle. In the first phase (follicular phase) following menstruation, estrogen levels are high while progesterone levels are low. In the second phase (luteal phase), progesterone levels are high. Females are often excluded from studies because researchers are concerned that the menstrual cycle might affect the results. The purpose of this study is to investigate the response to resistance exercise in each phase of the menstrual cycle.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Unilateral Resistance Exercise Leg | One leg will perform unilateral resistance exercise |
| OTHER | Control Leg | One leg will serve as a non-exercise control |
Timeline
- Start date
- 2022-05-01
- Primary completion
- 2023-03-01
- Completion
- 2024-04-30
- First posted
- 2022-04-26
- Last updated
- 2025-01-01
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05347667. Inclusion in this directory is not an endorsement.